Skip to main content

Advertisement

SpringerLink
Log in

Is It Really Duct Carcinoma In Situ?

  • Editorial
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCES

  1. Fisher B, Costantino J, Redmond C, et al. Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. N Engl J Med 1993;328:1581–1586.

    CAS  PubMed  Google Scholar 

  2. Fisher B, Dignam J, Wolmark N, et al. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from the National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol 1998;16:441–452.

    CAS  PubMed  Google Scholar 

  3. Fisher B, Dignam J, Wolmark N, et al. Tamoxifen in the treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial. Lancet 1999;353:1993–2000.

    Article  CAS  PubMed  Google Scholar 

  4. Julien J-P, Bijker N, Fentiman IS, et al. Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853. Lancet 2000;355:528–533.

    CAS  PubMed  Google Scholar 

  5. Fisher ER, Costantino J, Fisher B, Palekar AS, Redmond C, Mamounas E. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17. Intraductal carcinoma (ductal carcinoma in situ). The National Surgical Adjuvant Breast and Bowel Project Collaborating Investigators. Cancer 1995;75:1310–1319.

    CAS  PubMed  Google Scholar 

  6. Bijker N, Peterse JL, Duchateau L, et al. Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853. J Clin Oncol 2001;19:2263–2271.

    CAS  PubMed  Google Scholar 

  7. Liberman L, Vuolo M, Dershaw DD, et al. Epithelial displacement after stereotactic 11-gauge directional vacuum-assisted breast biopsy. AJR Am J Roentgenol 1999;172:677–681.

    CAS  PubMed  Google Scholar 

  8. Rosai J. Borderline epithelial lesions of the breast. Am J Surg Pathol 1991;15:209–221.

    Article  CAS  PubMed  Google Scholar 

  9. Silverstein MJ, Rosser RJ, Gierson ED, et al. Axillary lymph node dissection for intraductal breast carcinoma–is it indicated?. Cancer 1987;59:1819–1824.

    CAS  PubMed  Google Scholar 

  10. Cody HS. Clinical aspects of sentinel node biopsy. Breast Cancer Res 2001;3:104–108.

    PubMed  Google Scholar 

  11. Pendas S, Dauway E, Giuliano AE, Ku NN, Cox CE, Reintgen DS. Sentinel node biopsy in duct carcinoma in situ patients. Ann Surg Oncol 2000;7:15–20.

    CAS  PubMed  Google Scholar 

  12. Bass SS, Lyman GH, McCann CR, et al. Lymphatic Mapping and Sentinel Lymph Node Biopsy. Breast J 1999;5:288–295.

    PubMed  Google Scholar 

  13. Cox CE, Haddad F, Bass S, et al. Lymphatic mapping in the treatment of breast cancer. Oncology (Huntingt) 1998;12:1283–1292.

    CAS  Google Scholar 

  14. Bass SS, Dauway E, Mahatme A, Ku NN, Berman C, Reintgen D, Cox CE. Lymphatic mapping with sentinel lymph node biopsy in patients with breast cancers <1 centimeter (T1A-T1B). Am Surg 1999;65:857–861.

    CAS  PubMed  Google Scholar 

  15. Klauber-DeMore N, Tan LK, Liberman L, et al. Sentinel lymph node biopsy: is it indicated in patients with high-risk ductal carcinoma-in-situ and ductal carcinoma-in-situ with microinvasion?. Ann Surg Oncol 2000;7:636–642.

    CAS  PubMed  Google Scholar 

  16. Dowlatshahi K, Fan M, Snider HC, Habib FA. Lymph node micrometastases from breast carcinoma: reviewing the dilemma. Cancer 1997;80:1188–1197.

    CAS  PubMed  Google Scholar 

  17. Cote RJ, Peterson HF, Chaiwun B, et al. Role of immunohistochemical detection of lymph-node metastases in management of breast cancer. International Breast Cancer Study Group [see comments]. Lancet 1999;354:896–900.

    Article  CAS  PubMed  Google Scholar 

  18. Diel IJ, Kaufmann M, Costa SD, et al. Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status. JNCI 1996;88:1652–1664.

    CAS  PubMed  Google Scholar 

  19. Braun S, Pantel K, Muller P, et al. Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer. N Engl J Med 2000;342:525–533.

    Article  CAS  PubMed  Google Scholar 

  20. Silverstein MJ, Lagios MD, Martino S, et al. Outcome after invasive local recurrence in patients with ductal carcinoma in situ of the breast. J Clin Oncol 1998;16:1367–1373.

    CAS  PubMed  Google Scholar 

  21. Lagios MD, Silverstein MJ. Sentinel node biopsy for patients with DCIS: a dangerous and unwarranted direction. Ann Surg Oncol 2001;8:275–277.

    CAS  PubMed  Google Scholar 

  22. McMasters KM, Wong SL, Martin RCG, et al. Dermal injection of radioactive colloid is superior to peritumoral injection for breast cancer sentinel lymph node biopsy: results of a multi-institutional study. Ann Surg 2001;233:676–687.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Breast Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York

    Hiram S. Cody III MD, Nancy Klauber-DeMore MD, Patrick I. Borgen MD & Kimberly J. Van Zee MD

  2. Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY

    Hiram S. Cody III MD

Authors
  1. Hiram S. Cody III MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nancy Klauber-DeMore MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Patrick I. Borgen MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kimberly J. Van Zee MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hiram S. Cody III MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cody, H.S., Klauber-DeMore, N., Borgen, P.I. et al. Is It Really Duct Carcinoma In Situ?. Ann Surg Oncol 8, 617 (2001). https://doi.org/10.1007/s10434-001-0617-0

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10434-001-0617-0

Search

Navigation